Lynn Morris

28.7k total citations · 2 hit papers
275 papers, 13.8k citations indexed

About

Lynn Morris is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Lynn Morris has authored 275 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Virology, 141 papers in Infectious Diseases and 79 papers in Immunology. Recurrent topics in Lynn Morris's work include HIV Research and Treatment (202 papers), HIV/AIDS drug development and treatment (112 papers) and HIV/AIDS Research and Interventions (87 papers). Lynn Morris is often cited by papers focused on HIV Research and Treatment (202 papers), HIV/AIDS drug development and treatment (112 papers) and HIV/AIDS Research and Interventions (87 papers). Lynn Morris collaborates with scholars based in South Africa, United States and United Kingdom. Lynn Morris's co-authors include Penny L. Moore, Salim S. Abdool Karim, Carolyn Williamson, Elin S. Gray, Koleka Mlisana, John R. Mascola, Sengeziwe Sibeko, Quarraisha Abdool Karim, Constantinos Kurt Wibmer and Siamon Gordon and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lynn Morris

265 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

2010 1.9k citations Quarraisha Abdool Karim, Salim S. Abdool Karim et al. Science profile →
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

2021 657 citations Bronwen E. Lambson, Lynn Morris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn Morris South Africa	62	8.5k	7.3k	4.2k	2.8k	2.4k	275	13.8k
Julie Overbaugh United States	64	7.8k 0.9×	6.5k 0.9×	3.3k 0.8×	3.4k 1.2×	2.5k 1.1×	281	13.9k
Max Essex United States	83	12.9k 1.5×	11.7k 1.6×	6.7k 1.6×	6.8k 2.4×	2.8k 1.2×	548	24.2k
Peter B. Gilbert United States	51	5.9k 0.7×	4.8k 0.7×	3.2k 0.8×	2.5k 0.9×	2.5k 1.0×	309	11.8k
Feng Gao China	54	8.2k 1.0×	5.7k 0.8×	3.3k 0.8×	3.3k 1.2×	2.9k 1.2×	246	12.4k
Jay A. Levy United States	83	14.2k 1.7×	8.7k 1.2×	9.1k 2.2×	6.6k 2.4×	3.1k 1.3×	306	22.8k
Charles R. Rinaldo United States	66	9.4k 1.1×	8.0k 1.1×	6.6k 1.6×	7.2k 2.6×	1.8k 0.8×	347	19.6k
Jaap Goudsmit Netherlands	85	11.5k 1.3×	11.1k 1.5×	6.1k 1.5×	7.1k 2.5×	5.1k 2.2×	329	23.6k
Françoise Barré‐Sinoussi France	63	11.9k 1.4×	7.0k 1.0×	7.5k 1.8×	4.5k 1.6×	2.4k 1.0×	216	17.5k
Eric Hunter United States	65	10.1k 1.2×	5.7k 0.8×	4.1k 1.0×	4.0k 1.4×	4.2k 1.8×	297	14.9k
M. Juliana McElrath United States	63	8.2k 1.0×	4.4k 0.6×	7.5k 1.8×	3.4k 1.2×	4.4k 1.8×	261	15.1k

Countries citing papers authored by Lynn Morris

Since Specialization

Citations

This map shows the geographic impact of Lynn Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Morris more than expected).

Fields of papers citing papers by Lynn Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Morris. The network helps show where Lynn Morris may publish in the future.

Co-authorship network of co-authors of Lynn Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Morris. A scholar is included among the top collaborators of Lynn Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Morris. Lynn Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richardson, Simone I., Bronwen E. Lambson, Andrew R. Crowley, et al.. (2019). IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. PLoS Pathogens. 15(12). e1008064–e1008064. 53 indexed citations

Ledwaba, Johanna, Yasien Sayed, Visva Pillay, Lynn Morris, & Gillian Hunt. (2019). Low Frequency of Protease Inhibitor Resistance Mutations and Insertions in HIV-1 Subtype C Protease Inhibitor-Naïve Sequences. AIDS Research and Human Retroviruses. 35(7). 673–678. 9 indexed citations

Reh, Lucia, Carsten Magnus, Claus Kadelka, et al.. (2018). Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage. PLoS Pathogens. 14(1). e1006825–e1006825. 10 indexed citations

Johnson, E. L., Nicole A. Doria‐Rose, Jason Gorman, et al.. (2018). Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nature Communications. 9(1). 4136–4136. 6 indexed citations

Richardson, Simone I., Amy W. Chung, Harini Natarajan, et al.. (2018). HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. PLoS Pathogens. 14(4). e1006987–e1006987. 56 indexed citations

Sheng, Zizhang, Chaim A. Schramm, Mark Connors, et al.. (2016). Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection. PLoS Computational Biology. 12(5). e1004940–e1004940. 23 indexed citations

Johnston, Victoria, Karen Cohen, Lubbe Wiesner, et al.. (2013). Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch. The Journal of Infectious Diseases. 209(5). 711–720. 44 indexed citations

Karim, Quarraisha Abdool, Salim S. Abdool Karim, Janet Frohlich, et al.. (2010). Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science. 329(5996). 1168–1174. 1856 indexed citations breakdown →

Davis, Katie L., Frédéric Bibollet‐Ruche, Hui Li, et al.. (2008). Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma. Journal of Virology. 83(3). 1240–1259. 55 indexed citations

10.

Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations

11.

Gray, Elin S., Penny L. Moore, Ralph Pantophlet, & Lynn Morris. (2007). N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization. Journal of Virology. 81(19). 10769–10776. 40 indexed citations

12.

Moore, Penny L., Elin S. Gray, Isaac Choge, et al.. (2007). The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection. Journal of Virology. 82(4). 1860–1869. 125 indexed citations

13.

Walker, Polly, Isaac Choge, Tammy Meyers, et al.. (2007). Polymorphisms in Nef Associated with Different Clinical Outcomes in HIV Type 1 Subtype C-Infected Children. AIDS Research and Human Retroviruses. 23(2). 204–215. 20 indexed citations

14.

Morris, Lynn. (1992). Sexual experience and use of contraception among young adults in Latin America.. PubMed. 41(4). 27–40. 11 indexed citations

15.

Morris, Lynn, et al.. (1991). Survey of reproductive health in young adults, greater Santiago, 1988.. PubMed. 25(4). 293–305.

16.

Morris, Lynn, et al.. (1988). Demographic and practice characteristics of chiropractors.. PubMed. 11(2). 85–8. 4 indexed citations

17.

Gordon, Siamon, Paul R. Crocker, Lynn Morris, et al.. (1986). Localization and Function of Tissue Macrophages. Novartis Foundation symposium. 118. 54–67. 38 indexed citations

18.

Anderson, John E., et al.. (1977). Contraceptive use. Prevalence among married women in Albany, New York, health region, 1974.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 77(6). 933–7. 1 indexed citations

19.

Morris, Lynn, et al.. (1971). The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil.. PubMed. 23(1). 89–101. 6 indexed citations

20.

Morris, Lynn, et al.. (1964). ORAL POLIOMYELITIS VACCINES. REPORT OF SPECIAL ADVISORY COMMITTEE ON ORAL POLIOMYELITIS VACCINES TO THE SURGEON GENERAL OF THE PUBLIC HEALTH SERVICE.. PubMed. 190. 49–51. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact